These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20035502)

  • 1. Intracranial atherosclerotic disease: an update.
    Qureshi AI; Feldmann E; Gomez CR; Johnston SC; Kasner SE; Quick DC; Rasmussen PA; Suri MF; Taylor RA; Zaidat OO
    Ann Neurol; 2009 Dec; 66(6):730-8. PubMed ID: 20035502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results.
    Qureshi AI; Feldmann E; Gomez CR; Johnston SC; Kasner SE; Quick DC; Rasmussen PA; Suri MF; Taylor RA; Zaidat OO
    J Neuroimaging; 2009 Oct; 19 Suppl 1():1S-10S. PubMed ID: 19807850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, diagnosis and management of intracranial atherosclerotic disease.
    Jeng JS; Tang SC; Liu HM
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1423-32. PubMed ID: 20936929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial atherosclerotic disease: epidemiology, imaging and treatment.
    McTaggart RA; Jayaraman MV; Haas RA; Feldmann E
    Med Health R I; 2009 Dec; 92(12):412-4. PubMed ID: 20066829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with symptomatic intracranial atherosclerosis.
    Leung TW; Kwon SU; Wong KS
    Int J Stroke; 2006 Feb; 1(1):20-5. PubMed ID: 18706064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.
    Kozak O; Tariq N; Suri MF; Taylor RA; Qureshi AI
    Neurosurgery; 2011 Aug; 69(2):334-42; discussion 342-3. PubMed ID: 21430591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of intracranial atherosclerotic stenosis.
    Turan TN; Chimowitz MI
    Rev Neurol Dis; 2008; 5(3):117-24. PubMed ID: 18838951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of symptomatic intracranial arterial stenosis.
    Kasner SE
    J Neuroimaging; 2009 Oct; 19 Suppl 1():20S-1S. PubMed ID: 19807853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of patients with intracranial atherosclerotic disease.
    Gomez CR; Qureshi AI
    J Neuroimaging; 2009 Oct; 19 Suppl 1():25S-9S. PubMed ID: 19807855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis.
    Jiang WJ; Xu XT; Du B; Dong KH; Jin M; Wang QH; Ma N
    Neurology; 2007 Feb; 68(6):420-6. PubMed ID: 17283316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intracranial arterial stenosis.
    Taylor RA; Kasner SE
    Expert Rev Neurother; 2006 Nov; 6(11):1685-94. PubMed ID: 17144782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.
    Fiorella D; Turan TN; Derdeyn CP; Chimowitz MI
    J Neurointerv Surg; 2009 Jul; 1(1):35-9. PubMed ID: 21994103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Hussein HM; El-Gengaihy A; Abdelmoula M; K Suri MF
    Neurosurgery; 2008 May; 62(5):1053-60; discussion 1060-2. PubMed ID: 18580803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
    Kasner SE; Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Benesch CG; Sila CA; Jovin TG; Romano JG; Cloft HJ;
    Circulation; 2006 Jan; 113(4):555-63. PubMed ID: 16432056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study.
    Mazighi M; Tanasescu R; Ducrocq X; Vicaut E; Bracard S; Houdart E; Woimant F
    Neurology; 2006 Apr; 66(8):1187-91. PubMed ID: 16636236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.